ARCHIVES

CCOP Controversy Goes On: DCT Board Objects, Says It Was Left Out; Moorhead, DeVita Clarify Positions

This article is from The Cancer Letter archive.

Vol. 08 No. 08 | February 19, 1982

Download PDF Visit The Full Archive

Related Articles

Recurrent Multiple Myeloma Responds To Revimid In Phase II, Side Effects Tolerable

January 31, 2003

ODAC Recommends Approval of Evista for Breast Cancer Risk Reduction.

July 27, 2007

In Brief: Clinton Backs Ban On Human Cloning; Wisconsin Selects Niederhuber As Director

June 13, 1997

Report Urges Better Working Conditions For Postdocs.

October 6, 2000

In Aftermath of NEJM Article, Critic Bailar Declares The Defeat Of Cancer Treatment

June 6, 1997

Rauscher, ACS Oppose Kennedy Bill, Defend NCI Special Authority, Say Funding Level Inadequate

May 11, 1979